Skip to main content

Table 2 Associations of PAI-1 levels and metabolic parameters, BMD and bone turnover markers; association of L-BMD and metabolic parameters, PAI-1 and bone turnover markers

From: Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

PAI-1 r p L-BMD r p
Age (year) −0,2375 0,011 Age (year)   
BMI (kg/m2) 0,3453 0,000 BMI (kg/m2) 0,347 0,000
Diabetes duration (year) -0,3046 0,002 Diabetes duration (year) 0,297 0,000
Insulin (mIU/L) 0,4411 0,000 Insulin (mIU/L) −0,232 0,018
Triglycerides (mmol/L) 0,4704 0,000 Triglycerides (mmol/L)   
HDL (mmol/L) -0,3331 0,001 LDL (mmol/L) -0,1956 0,041
Osteocalcin (ng/ml) -0,2976 0,002 PAI-1 0,119 0,046
Pyrilinks (nMPD/mMc) -0,2897 0,002 Osteocalcin (ng/ml) −0,318 0,001
Crosslaps (ng/ml) -0,2955 0,002 Pyrilinks (nMPD/mMc) −0,302 0,001
Lumbar BMD (g/cm2) 0,1990 0,046 Crosslaps (ng/ml) −0,24 0,012
Hip BMD (g/cm2) 0,3530 0,000    
  1. PAI 1 plasminogen activator inhibitor 1, BMD bone mineral density, BMI body mass index, HDL high density lipoprotein